Your browser doesn't support javascript.
loading
FOCUS--Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists.
Stiefl, Nikolaus; Gedeck, Peter; Chin, Donovan; Hunt, Peter; Lindvall, Mika; Spiegel, Katrin; Springer, Clayton; Biller, Scott; Buenemann, Christoph; Kanazawa, Takanori; Kato, Mitsunori; Lewis, Richard; Martin, Eric; Polyakov, Valery; Tommasi, Ruben; van Drie, John; Vash, Brian; Whitehead, Lewis; Xu, Yongjin; Abagyan, Ruben; Raush, Eugene; Totrov, Max.
Afiliación
  • Stiefl N; †Novartis Institute for Biomedical Research, Postfach, CH-4002 Basel, Switzerland.
  • Gedeck P; ‡Novartis Institute for Tropical Diseases Pte. Ltd., 10 Biopolis Road, #05-01 Chromos, Singapore 138670.
  • Chin D; §Novartis Institute for Biomedical Research, 250 Massachusetts Ave., Cambridge, Massachusetts 02139, United States.
  • Hunt P; ∥Novartis Institute for Biomedical Research, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom.
  • Lindvall M; ⊥Novartis Institute for Biomedical Research, 4560 Horton Street, Bldg. 4, Emeryville, California 94608, United States.
  • Spiegel K; ∥Novartis Institute for Biomedical Research, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom.
  • Springer C; §Novartis Institute for Biomedical Research, 250 Massachusetts Ave., Cambridge, Massachusetts 02139, United States.
  • Biller S; §Novartis Institute for Biomedical Research, 250 Massachusetts Ave., Cambridge, Massachusetts 02139, United States.
  • Buenemann C; #Novartis Institute for Biomedical Research, 11/2 Muthgasse, 1190 Wien, Austria.
  • Kanazawa T; ∇Novartis Institutes for BioMedical Research, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan.
  • Kato M; §Novartis Institute for Biomedical Research, 250 Massachusetts Ave., Cambridge, Massachusetts 02139, United States.
  • Lewis R; ∇Novartis Institutes for BioMedical Research, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan.
  • Martin E; †Novartis Institute for Biomedical Research, Postfach, CH-4002 Basel, Switzerland.
  • Polyakov V; ⊥Novartis Institute for Biomedical Research, 4560 Horton Street, Bldg. 4, Emeryville, California 94608, United States.
  • Tommasi R; ⊥Novartis Institute for Biomedical Research, 4560 Horton Street, Bldg. 4, Emeryville, California 94608, United States.
  • van Drie J; §Novartis Institute for Biomedical Research, 250 Massachusetts Ave., Cambridge, Massachusetts 02139, United States.
  • Vash B; §Novartis Institute for Biomedical Research, 250 Massachusetts Ave., Cambridge, Massachusetts 02139, United States.
  • Whitehead L; §Novartis Institute for Biomedical Research, 250 Massachusetts Ave., Cambridge, Massachusetts 02139, United States.
  • Xu Y; §Novartis Institute for Biomedical Research, 250 Massachusetts Ave., Cambridge, Massachusetts 02139, United States.
  • Abagyan R; ⊥Novartis Institute for Biomedical Research, 4560 Horton Street, Bldg. 4, Emeryville, California 94608, United States.
  • Raush E; ○Molsoft L.L.C., 11199 Sorrento Valley Road, S209, San Diego, California 92121, United States.
  • Totrov M; ○Molsoft L.L.C., 11199 Sorrento Valley Road, S209, San Diego, California 92121, United States.
J Chem Inf Model ; 55(4): 896-908, 2015 Apr 27.
Article en En | MEDLINE | ID: mdl-25816021
Communication of data and ideas within a medicinal chemistry project on a global as well as local level is a crucial aspect in the drug design cycle. Over a time frame of eight years, we built and optimized FOCUS, a platform to produce, visualize, and share information on various aspects of a drug discovery project such as cheminformatics, data analysis, structural information, and design. FOCUS is tightly integrated with internal services that involve-among others-data retrieval systems and in-silico models and provides easy access to automated modeling procedures such as pharmacophore searches, R-group analysis, and similarity searches. In addition, an interactive 3D editor was developed to assist users in the generation and docking of close analogues of a known lead. In this paper, we will specifically concentrate on issues we faced during development, deployment, and maintenance of the software and how we continually adapted the software in order to improve usability. We will provide usage examples to highlight the functionality as well as limitations of FOCUS at the various stages of the development process. We aim to make the discussion as independent of the software platform as possible, so that our experiences can be of more general value to the drug discovery community.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Simulación por Computador / Química Farmacéutica / Comunicación / Descubrimiento de Drogas Idioma: En Revista: J Chem Inf Model Asunto de la revista: INFORMATICA MEDICA / QUIMICA Año: 2015 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Simulación por Computador / Química Farmacéutica / Comunicación / Descubrimiento de Drogas Idioma: En Revista: J Chem Inf Model Asunto de la revista: INFORMATICA MEDICA / QUIMICA Año: 2015 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos